Artificial intelligence-driven radiosurgery for brain metastases

人工智能驱动的脑转移放射外科治疗

• 批准号: 2886553
• 金额: --
• 依托单位: King's College London
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2886553
• 关键词: Artificial; intelligence; driven; radiosurgery; brain

Aims of the Project:Implement learning-based registration to curate a spatially-normalised dataset of MR images previously used to deliver stereotactic radiosurgery to brain metastasesDevelop data-driven deep learning frameworks to automatically detect and segment brain metastases while allowing for interactive correctionsDevelop imaging biomarkers to predict tumour response and behaviour following treatmentApproximately 25,000 patients are diagnosed with a brain tumour every year in the UK. Brain metastases affect up to 40% of patients with extracranial primary cancer. Furthermore, although there are presently no reliable data, metastatic brain tumours are thought to outnumber primary malignant brain tumours by at least 3:1. Patients with brain metastases require individualized patient management and may include surgery, stereotactic radiosurgery, fractionated radiotherapy and chemotherapy, either alone or in combination.Brain metastases most commonly occur in patients with lung, breast, kidney, melanoma or bowel cancer. Surgery, stereotactic radiosurgery (SRS), and whole-brain radiotherapy (WBRT) continue to be the mainstay of treatment for brain metastasis. In particular, SRS has emerged as an important modality for treating intracranial metastases. The most important criteria for choosing SRS or WBRT is the overall number of metastases. SRS is the preferred treatment modality for patients with 1-10 metastases although the number of clinicians treating multiple metastases is increasing and several centres routinely treat over 10-20+ metastases. The planning of SRS treatment is significantly impacted by the number of metastases. The presence of small micro-metastases can greatly increase the length of planning time, as a result of having to carefully scrutinise the imaging data to detect and segment all the tumours. Furthermore, lifelong radiological follow-up is required for all patients with brain metastases, even after they undergo treatment, placing an additional burden on healthcare resources. An automated segmentation tool could significantly improve clinical workflow during the planning of SRS. By using an AI segmentation tool as an initialisation step in a clinician-driven interactive process, we will improve workflow and operational efficiency.Artificial intelligence (AI) refers to computing technologies that mimic processes associated with human intelligence. We have previously developed a fully-automated AI framework to segment a vestibular schwannoma (another type of brain tumour) from MRI achieving state-of-the-art results.This project now aims to develop deep learning models to: 1) detect and automatically segment brain metastases using MRI while allowing for user-driven corrections; and 2) develop composite clinical and imaging biomarkers to predict tumour response and behaviour following gamma knife treatment. The dataset and learning from this project will provide the foundation of an ambitious research programme aiming at translating such tools in clinical practice by making the AI tools flexible enough to seamlessly integrate into the clinical workflow. This will require the design of interactive corrections, the provision of interpretability means, and the development of proven AI trustworthiness features.

该项目的目的：实施基于学习的配准，以管理先前用于向脑转移瘤提供立体定向放射外科手术的MR图像的空间标准化数据集开发数据驱动的深度学习框架，以自动检测和分割脑转移瘤，同时允许交互式校正开发成像生物标志物，以预测治疗后的肿瘤反应和行为在英国，每年约有25，000名患者被诊断患有脑肿瘤。脑转移影响了40%的颅外原发性癌症患者。此外，虽然目前没有可靠的数据，但转移性脑肿瘤被认为至少比原发性恶性脑肿瘤多3：1。脑转移瘤患者需要个体化的患者管理，可能包括手术、立体定向放射外科手术、分次放疗和化疗，单独或联合使用。脑转移瘤最常见于肺癌、乳腺癌、肾癌、黑色素瘤或肠癌患者。手术、立体定向放射外科（SRS）和全脑放疗（WBRT）仍然是脑转移瘤治疗的主要手段。特别是，SRS已成为治疗颅内转移瘤的重要方式。选择SRS或WBRT的最重要标准是转移的总数。SRS是1-10个转移瘤患者的首选治疗方式，尽管治疗多发性转移瘤的临床医生数量正在增加，一些中心常规治疗超过10-20个转移瘤。SRS治疗的计划受到转移瘤数量的显著影响。微小转移瘤的存在可能会大大增加计划时间的长度，因为必须仔细检查成像数据以检测和分割所有肿瘤。此外，所有脑转移患者都需要终身放射学随访，即使在接受治疗后也是如此，这给医疗资源带来了额外负担。自动分割工具可以显著改善SRS计划期间的临床工作流程。通过使用人工智能分割工具作为临床医生驱动的交互过程中的初始化步骤，我们将改善工作流程和运营效率。人工智能（AI）是指模仿与人类智能相关的过程的计算技术。我们之前已经开发了一个全自动的AI框架来分割前庭神经鞘瘤该项目现在的目标是开发深度学习模型，以：1）使用MRI检测并自动分割脑转移瘤，同时允许用户驱动的校正;和2）开发复合临床和成像生物标志物以预测伽玛刀治疗后的肿瘤反应和行为。该项目的数据集和学习将为一项雄心勃勃的研究计划提供基础，该计划旨在通过使人工智能工具足够灵活，以无缝集成到临床工作流程中，从而在临床实践中翻译这些工具。这将需要设计交互式更正，提供可解释性手段，并开发经过验证的AI可信度功能。